JEBSEN MICHAEL B (CFO) reported 1 transaction at TENAX THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/7/2018ACC: 0001481436-18-000003
Officer· CFO
Since Aug 2018
+5.72K
Net shares
Net buyer
$35.8K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
5.72K acquired
Non-Derivative Transactions1
common stock
Direct
Shares
+5.72K
Price / share
$6.25
Trade value
$35.75K
% of position
19.8%
7/31/2018
28.96K→34.68K
Total
Net shares
+5.72K
Net value
$35.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| common stock Direct | 7/31/2018 | D · Disposition | +5.72K | $6.25 | $35.75K | 19.8% | 28.96K | 34.68K |
| Total | +5.72K | $35.75K | ||||||
Derivative Transactions0
No derivative transactions reported